Literature DB >> 23225386

Patient-identified disease burden in facioscapulohumeral muscular dystrophy.

Nicholas E Johnson1, Christine Quinn, Eileen Eastwood, Rabi Tawil, Chad R Heatwole.   

Abstract

INTRODUCTION: The multitude of symptoms associated with facioscapulohumeral muscular dystrophy (FSHD) disease burden are of varying importance. The extent of these symptoms and their cumulative effect on the FSHD population is unknown.
METHODS: We conducted interviews with adult FSHD patients to identify which symptoms have the greatest effect on their lives. Each interview was recorded, transcribed, coded, and analyzed using a qualitative framework technique, triangulation, and a three-investigator consensus approach.
RESULTS: One thousand three hundred seventy-five quotes were obtained through 20 patient interviews. Two hundred fifty-one symptoms of importance were identified representing 14 themes of FSHD disease burden. Symptoms associated with mobility impairment, activity limitation, and social role limitation were most frequently mentioned by participants.
CONCLUSIONS: There are multiple themes and symptoms, some previously underrecognized, that play a key role in FSHD disease burden.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23225386      PMCID: PMC4097080          DOI: 10.1002/mus.23529

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  28 in total

Review 1.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

2.  Neovascular glaucoma from advanced Coats disease as the initial manifestation of facioscapulohumeral dystrophy in a 2-year-old child.

Authors:  Carol L Shields; Jonathan Zahler; Naomi Falk; Minoru Furuta; Ralph C Eagle; Luis E Bello Espinosa; Philip R Fischer; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2007-06

3.  Studies in disorders of muscle. II Clinical manifestations and inheritance of facioscapulohumeral dystrophy in a large family.

Authors:  F H TYLER; F E STEPHENS
Journal:  Ann Intern Med       Date:  1950-04       Impact factor: 25.391

Review 4.  Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions.

Authors:  Jeffrey M Statland; Rabi Tawil
Journal:  Curr Opin Neurol       Date:  2011-10       Impact factor: 5.710

5.  Role of disease severity, illness perceptions, and mood on quality of life in muscle disease.

Authors:  Michael R Rose; Reza Sadjadi; John Weinman; Tayyaba Akhtar; Shree Pandya; John T Kissel; Carlayne E Jackson
Journal:  Muscle Nerve       Date:  2012-09       Impact factor: 3.217

6.  Severe fascioscapulohumeral muscular dystrophy presenting with Coats' disease and mental retardation.

Authors:  Laurence A Bindoff; Nanette Mjellem; Kristian Sommerfelt; Bård K Krossnes; Fiona Roberts; Jørgen Krohn; Randi Skarpaas Tranheim; Irene D Haggerty
Journal:  Neuromuscul Disord       Date:  2006-08-28       Impact factor: 4.296

7.  Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases.

Authors:  V A Sansone; M Panzeri; M Montanari; G Apolone; S Gandossini; M R Rose; L Politano; C Solimene; G Siciliano; L Volpi; C Angelini; A Palmieri; A Toscano; O Musumeci; T Mongini; L Vercelli; R Massa; M B Panico; M Grandi; G Meola
Journal:  Eur J Neurol       Date:  2010-03-30       Impact factor: 6.089

Review 8.  A systematic review of quality of life in adults with muscle disease.

Authors:  Christopher D Graham; Michael R Rose; Elizabeth A Grunfeld; Simon D Kyle; John Weinman
Journal:  J Neurol       Date:  2011-05-20       Impact factor: 4.849

9.  Quality of life and pain in patients with facioscapulohumeral muscular dystrophy.

Authors:  Luca Padua; Irene Aprile; Roberto Frusciante; Elisabetta Iannaccone; Monica Rossi; Rosaria Renna; Sonia Messina; Giuseppina Frasca; Enzo Ricci
Journal:  Muscle Nerve       Date:  2009-08       Impact factor: 3.217

10.  Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.

Authors:  Joke S Kalkman; Machiel J Zwarts; Maartje L Schillings; Baziel G M van Engelen; Gijs Bleijenberg
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

View more
  21 in total

1.  Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.

Authors:  Bryan P Fitzgerald; Kelly M Conn; Joanne Smith; Andrew Walker; Amy L Parkhill; James E Hilbert; Elizabeth A Luebbe; Richard T Moxley
Journal:  J Neurol       Date:  2016-10-12       Impact factor: 4.849

2.  A Qualitative Approach to Health Related Quality-of-Life in Congenital Muscular Dystrophy.

Authors:  Kylie M Cornwall; Russell J Butterfield; Antonio Hernandez; Chad Heatwole; Nicholas E Johnson
Journal:  J Neuromuscul Dis       Date:  2018

Review 3.  Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy.

Authors:  Justin Cohen; Alec DeSimone; Monkol Lek; Angela Lek
Journal:  Trends Mol Med       Date:  2020-10-19       Impact factor: 11.951

4.  Patient identification of the symptomatic impact of charcot-marie-tooth disease type 1A.

Authors:  Nicholas E Johnson; Chad R Heatwole; Michele Ferguson; Janet E Sowden; Shanie Jeanat; David N Herrmann
Journal:  J Clin Neuromuscul Dis       Date:  2013-09

5.  Facioscapulohumeral muscular dystrophy functional composite outcome measure.

Authors:  Katy Eichinger; Chad Heatwole; Stanley Iyadurai; Wendy King; Lindsay Baker; Susanne Heininger; Amy Bartlett; Nuran Dilek; William B Martens; Michael Mcdermott; John T Kissel; Rabi Tawil; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2018-01-30       Impact factor: 3.217

6.  Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy.

Authors:  Carlos Capella-Peris; Mary M Cosgrove; Irene C Chrismer; Magalie Emile-Backer; M Sonia Razaqyar; Jeffrey S Elliott; Anna Kuo; Paul G Wakim; Katherine G Meilleur
Journal:  Qual Life Res       Date:  2020-02-10       Impact factor: 4.147

7.  The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy.

Authors:  Sarah Youssof
Journal:  Muscle Nerve       Date:  2016-03-01       Impact factor: 3.217

Review 8.  Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.

Authors:  Johanna Hamel; Rabi Tawil
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

9.  Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).

Authors:  Chad Heatwole; Nicholas Johnson; Rita Bode; Jeanne Dekdebrun; Nuran Dilek; James E Hilbert; Elizabeth Luebbe; William Martens; Michael P McDermott; Christine Quinn; Nan Rothrock; Charles Thornton; Barbara G Vickrey; David Victorson; Richard T Moxley
Journal:  Neurology       Date:  2015-11-18       Impact factor: 9.910

10.  Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).

Authors:  Johanna Hamel; Nicholas Johnson; Rabi Tawil; William B Martens; Nuran Dilek; Michael P McDermott; Chad Heatwole
Journal:  Neurology       Date:  2019-08-13       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.